skip to main content

Breast Cancer

Men and Breast Cancer

There is no question that breast cancer disproportionately affects women, but we shouldn't be so quick to dismiss the risk to men. As we continue to learn more about the ways our genes influence our cancer risk, involvement of male relatives in genetic counseling and genetic testing can provide important information for your family's breast cancer risk evaluation.

AACR recognizes Max Wicha for significant contributions to breast cancer research

Date Visible: 
Thursday, December 1, 2016 - 14:15

Max S. Wicha, M.D., will receive the ninth annual Distinguished Lectureship in Breast Cancer Research from the American Association for Cancer Research. Wicha will present a special lecture as part of the 2016 San Antonio Breast Cancer Symposium.

Is our treatment of DCIS psychologic rather than oncologic?

There has been a lot of confusion since the study was published in September, 2015 examining mortality after a DCIS diagnosis. Specifically, the study looked at differences in outcome among women who were treated for DCIS by different methods. The differences among these women did not provide evidence that no treatment is an option.

DCIS, LCIS – Do I have breast cancer?

Lobular Carcinoma in situ (LCIS) and Ductal Carcinoma in situ (DCIS) are abnormalities that doctors call "stage zero" breast cancer. Women with either of these diagnoses often ask us, "Do I have breast cancer?"

I found a lump in my breast, what next?

Whether it was discovered during a breast self-exam or incidentally as you were putting on your deodorant, finding a breast lump can be terrifying. Somehow it seems human nature for us to think the worst when we find a mass or lump anywhere there should not be one.

One-Third of Breast Cancer Patients Consult PCPs About Treatment Options

As more people survive cancer, primary care physicians and oncologists must work together to manage patient care. That’s because once cancer treatment ends, patients eventually transition back to their primary care physician.

Precision medicine test helps guide breast cancer patients’ chemotherapy decision

Date Visible: 
Monday, October 24, 2016 - 10:45

One of the earliest widespread applications of precision medicine in cancer care is helping patients and physicians decide whether chemotherapy is needed, a new study finds.

Transcription factor can stifle breast cancer suppressing gene

Date Visible: 
Tuesday, October 18, 2016 - 11:00

A transcription factor known as Snail1 can act as a “molecular bypass” that diminishes the natural tumor suppressing action of a gene called p53 in breast cancer patients, a new study finds.

How a small implanted device could help limit metastatic breast cancer

Date Visible: 
Thursday, September 15, 2016 - 11:00

A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the growth of tumors.

Pages